OrbiMed Capital GP IV LLC, 10% Owner at Audentes Therapeutics, Inc. (BOLD), sold 290,496 shares at $34.67 ($10.2M) on 2018-03-09, disclosed to the SEC on 2018-03-12.
Open-market sale of $10.2M BOLD by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.06 | 58,428 | $2.0M | 19.6% |
| 2 | $34.06 | 58,428 | $2.0M | 19.6% |
| 3 | $34.67 | 21,300 | $738K | 7.3% |
| 4 | $35.86 | 47,395 | $1.7M | 16.7% |
| 5 | $35.86 | 47,395 | $1.7M | 16.7% |
| 6 | $36.44 | 11,305 |
| $412K |
| 4.1% |
| 7 | $36.44 | 11,305 | $412K | 4.1% |
| 8 | $34.92 | 16,937 | $591K | 5.8% |
| 9 | $34.92 | 16,937 | $591K | 5.8% |
| 10 | $36.04 | 1,066 | $38K | 0.4% |
| Total | $34.98 avg | 290,496 | $10.2M | 100% |
| Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |
| OTIC | SELL | 2015-11-19 | $4.0M | — | Filing → |